Cloxyquin has been reported as a specific activator of TRESK [TWIK-related spinal cord K 1 channel (also known as K 2P 18.1)] background potassium channel. In this study, we have synthetized chemically modified analogs of cloxyquin and tested their effects on TRESK and other K 2P channels. The currents of murine K 2P channels, expressed heterologously in Xenopus oocytes, were measured by two-electrode voltage clamp, whereas the native background K 1 conductance of mouse dorsal root ganglion (DRG) neurons was examined by the whole-cell patch-clamp method. Some of the analogs retained the activator character of the parent compound, but, more interestingly, other derivatives inhibited mouse TRESK current. The inhibitor analogs (A2764 and A2793) exerted state-dependent effects. The degree of inhibition by 100 mM A2764 (77.8% 6 3.5%, n 5 6) was larger in the activated state of TRESK (i.e., after calcineurin-dependent stimulation) than in the resting state of the channel (42.8% 6 11.5% inhibition, n 5 7). The selectivity of the inhibitor compounds was tested on several K 2P channels. A2793 inhibited TWIKrelated acid-sensitive K 1 channel (TASK)-1 (100 mM, 53.4% 6 13, 5%, n 5 5), while A2764 was more selective for TRESK, it only moderately influenced TREK-1 and TWIK-related alkaline pH-activated K 1 channel. The effect of A2764 was also examined on the background K 1 currents of DRG neurons. A subpopulation of DRG neurons, prepared from wild-type animals, expressed background K 1 currents sensitive to A2764, whereas the inhibitor did not affect the currents in the DRG neurons of TRESK-deficient mice. Accordingly, A2764 may prove to be useful for the identification of TRESK current in native cells, and for the investigation of the role of the channel in nociception and migraine.
SIGNIFICANCE STATEMENTTRESK background potassium channel is a potential pharmacological target in migraine and neuropathic pain. In this study, we have identified a selective inhibitor of TRESK, A2764. This compound can inhibit TRESK in native cells, leading to cell depolarization and increased excitability. This new inhibitor may be of use to probe the role of TRESK channel in migraine and nociception.